ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

15,095Medicare Part D Prescriptions Filled, Including Refills
$729K Total Retail Price of All Prescriptions
470 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
LISINOPRIL 790 651
SIMVASTATIN 734 639
AMLODIPINE BESYLATE 468 438
OMEPRAZOLE 457 404
FUROSEMIDE 416 388
CITALOPRAM HBR 413 365
WARFARIN SODIUM 410 390
LEVOTHYROXINE SODIUM 378 359
METOPROLOL TARTRATE 373 356
HYDROCHLOROTHIAZIDE 369 338
HYDROCODONE-ACETAMINOPHEN 334 195 S3
ATENOLOL 334 310
ADVAIR DISKUS 299 231
METFORMIN HCL 296 218
PREDNISONE 289 248
GABAPENTIN 231 195
TRAZODONE HCL 207 186
DONEPEZIL HCL 205 205
METOPROLOL SUCCINATE 198 183
GLYBURIDE 188 116 R
PROAIR HFA 187 139
MIRTAZAPINE 185 182
NAMENDA 165 165
ATORVASTATIN CALCIUM 147 133
SPIRIVA 145 105
DIGOXIN 139 135
FAMOTIDINE 124 107
OXYCODONE HCL 110 41 S2
TRAMADOL HCL 110 96
ZOLPIDEM TARTRATE 105 31
FLOVENT HFA 101 71
COMBIVENT 100 57
LOSARTAN POTASSIUM 93 67
OXYCODONE-ACETAMINOPHEN 93 48 S2
LANTUS 93 91
DIOVAN 91 91
PRAVASTATIN SODIUM 88 51
AZITHROMYCIN 88 61
RANITIDINE HCL 80 57
GLIMEPIRIDE 78 71
IBUPROFEN 76 42
AMITRIPTYLINE HCL 76 65 R
SYMBICORT 76 58
RISPERIDONE 75 75
FLUTICASONE PROPIONATE 75 65
CARBIDOPA-LEVODOPA 72 72
ALLOPURINOL 70 62
POTASSIUM CHLORIDE 70 70
IPRATROPIUM-ALBUTEROL 68 67
DOXYCYCLINE HYCLATE 67 61
GLIPIZIDE 66 65
ALENDRONATE SODIUM 63 54
TAMSULOSIN HCL 62 62
FLUOXETINE HCL 58 43
SERTRALINE HCL 57 57
CYMBALTA 55 44
CARISOPRODOL 55 15 R
NITROGLYCERIN PATCH 55 55
NEXIUM 55 43
LORAZEPAM 53 53
DILTIAZEM 24HR CD 52 52
SULFAMETHOXAZOLE-TRIMETHOPRIM 52 50
MECLIZINE HCL 51 44
METFORMIN HCL ER 50 36
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.